Dasatinib

• Target :

  Apoptosis|||Autophagy|||c-Kit|||Src|||Bcr-Abl

• Related Pathways :

  Autophagy|||Angiogenesis|||Tyrosine Kinase/Adaptors|||Apoptosis|||Cytoskeletal Signaling

• Purity :

  0.9989

• Bioactivity :

  Dasatinib (BMS-354825) is an orally active, ATP-competitive tyrosine kinase inhibitor that targets Src and Bcr-Abl (Ki=16/30 pM), with antitumor activity, used in the treatment of leukemia and lymphoma.

• Smiles :

  N(C1=CC(N2CCN(CCO)CC2)=NC(C)=N1)C=3SC(C(NC4=C(C)C=CC=C4Cl)=O)=CN3

• Molecular Formula :

  C22H26ClN7O2S

• Molecular Weight :

  488.01

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  302962-49-8